Market Access China’s 4+7 drug procurement policy and its impact on the ph... It is estimated that China has around 10,000 pharmaceutical companies varying in size, strategy, and technology.
R&D Reuters Pharma Europe 2024 – Peter Stenico Pioneering access to biosimilars is crucial for strengthening health equity by providing affordable, life-changing therapies to patients worldwide.
Digital Fixing clinical trial data management It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.